GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adherium Ltd (ASX:ADRDA) » Definitions » Current Accrued Expense

Adherium (ASX:ADRDA) Current Accrued Expense : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Adherium Current Accrued Expense?

Adherium's Current Accrued Expense for the quarter that ended in Dec. 2023 was A$0.00 Mil.


Adherium Current Accrued Expense Historical Data

The historical data trend for Adherium's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adherium Current Accrued Expense Chart

Adherium Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Current Accrued Expense
Get a 7-Day Free Trial - - - - -

Adherium Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Adherium Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Adherium Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Adherium's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Adherium (ASX:ADRDA) Business Description

Traded in Other Exchanges
N/A
Address
333 Collins Street, Level 14, Melbourne, VIC, AUS, 3000
Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. Geographically, it derives a majority of its revenue from Europe and also has a presence in New Zealand and Australia; North America, and Asia.

Adherium (ASX:ADRDA) Headlines

No Headlines